Measures · D13 in 2027 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing
Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)
Drug PlanMedication SafetySource: Prescription Drug Events
- What it measures
- The use of multiple anticholinergics in older adults is associated with an increased risk of cognitive decline.
- How it's calculated
- This measure is defined as the percentage of Part D beneficiaries 65 years of age or older with concurrent use of two or more unique anticholinergic (ACH) medications during the measurement period. Concurrent use is defined as overlapping days’ supply for at least 30 cumulative days during the measurement period. Continuous enrollment (CE) is defined as continuously enrolled in a Medicare Part D contract during the measurement period, with one allowable gap in enrollment of up to one calendar month. The percentage is calculated as the number of CE beneficiaries in the denominator with concurrent use for at least 30 cumulative days of two or more unique ACH medications, each with at least two prescription claims with different dates of service (DOS), during the measurement period (numerator) divided by the number of CE beneficiaries, 65 years or older, with at least two prescription claims with different DOS of the same ACH medication during the measurement period (denominator). Note, the earliest DOS for any target medication with at least two prescription claims on different DOS, should be at least 30 days from the last day of the measurement period. The Poly-ACH measure is adapted from the Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults measure developed and endorsed by the Pharmacy Quality Alliance (PQA). See the medication list for this measure. The Poly-ACH measure is calculated using the NDC lists updated by the PQA. The complete NDC lists are posted along with these technical notes.
- Data source
- Prescription Drug Event (PDE) The data for this measure come from Prescription Drug Event (PDE) data submitted by drug plans to the CMS DDPS and accepted by the 2025 PDE submission deadline for annual Part D payment reconciliation with dates of service from January 1, 2025 – December 31, 2025. If the PDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the Patient Safety measure calculations. If the PDE edit is informational and therefore does not result in the PDE being rejected, then the PDE is used in the Patient Safety measure calculations. Reminder, CMS uses the term “final action” PDE to describe the most recently accepted original, adjustment, or deleted PDE record representing a single dispensing event. Original and adjustment final action PDEs submitted by the sponsor and accepted by DDPS prior to the 2025 PDE submission deadline are used to calculate this measure. PDE adjustments made post- reconciliation were not reflected in this measure. Additional data sources include the CME. The data cutoff date for all the additional data sources listed below such as the CME is determined by the same PDE submission deadline for the annual Part D payment reconciliation. • CME is used for enrollment information and to identify beneficiaries who elected to receive hospice care.
- Measurement period
- 01/01/2025 – 12/31/2025
- Better when
- Lower
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- Exclusions
Show
Contracts with 29 or fewer continuously enrolled beneficiaries (in the denominator). The following beneficiaries are excluded from the denominator if at any time during the measurement period: • In hospice- Notes
- Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the PQA medication or NDC lists, are excluded from CMS analyses.
- Disaster policy
- Higher measure star (2026-2027) for contracts with 25% or more enrolled affected by 2025 disasters.
From the 2027 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2027 star distribution
Not rated: Plan too new to be measured (94); Not enough data available (46); Plan not required to report measure (8)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | > 15 % | > 11 % to <= 15 % | > 7 % to <= 11 % | > 5 % to <= 7 % | <= 5 % |
| 2027 | PDP | > 7 % | > 6 % to <= 7 % | > 4 % to <= 6 % | > 1 % to <= 4 % | <= 1 % |
Lowest-scoring contracts, 2027
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H9909 American Health Advantage of MS | Mitchell Family Office | 774 | 23 | 1 | — | 16 | 0% |
| S4983 Kaiser Permanente | Kaiser Foundation Health Plan, Inc. | 6,628 | 15 | 1 | — | 11 | 0% |
| H9066 Nascentia Health Plus | VISITING NURSE ASSOCIATION OF CENTRAL NEW YORK | 663 | 23 | 1 | — | 16 | 0% |
| H9986 Florida Complete Care | Independent Living Systems, LLC | 1,218 | 21 | 1 | — | 14 | 0% |
| H7524 Excellus Health Plan Community Care LLC | Lifetime Healthcare, Inc. | 2,124 | 20 | 1 | — | 13 | 1% |
| H8492 American Health Advantage of Louisiana | Mitchell Family Office | 729 | 19 | 1 | — | 12 | 1% |
| H2392 Kansas Health Advantage | Kansas Superior Select | 873 | 19 | 1 | — | 12 | 1% |
| H3814 ATRIO Health Plans | ATRIO Health Plans | 1,997 | 19 | 1 | — | 12 | 1% |
| H1119 Valor Health Plan | The Schroer Group, Inc. | 2,494 | 19 | 1 | — | 12 | 1% |
| H8797 Perennial Advantage | Perennial Consortium, LLC | 1,609 | 19 | 1 | — | 12 | 1% |
| H0169 UnitedHealthcare | UnitedHealth Group, Inc. | 102,010 | 18 | 1 | — | 11 | 2% |
| H9191 Provider Partners Health Plans | Rifkin Managed Care Holding, LLC | 1,339 | 18 | 1 | — | 11 | 2% |
| H6595 UnitedHealthcare | UnitedHealth Group, Inc. | 29,803 | 18 | 1 | — | 11 | 2% |
| H6345 PruittHealth Premier | UNICO Services, Inc. | 882 | 18 | 1 | — | 11 | 2% |
| H6396 CareSource MyCare Ohio (HMO D-SNP) | CareSource | 40,849 | 18 | 1 | — | 11 | 2% |
| H9590 Longevity Health | Longevity Health Founders, LLC | 976 | 18 | 1 | — | 11 | 2% |
| H5209 Molina Healthcare of Wisconsin | Molina Healthcare, Inc. | 2,918 | 18 | 1 | — | 11 | 2% |
| S5820 UnitedHealthcare | UnitedHealth Group, Inc. | 355,415 | 9 | 1 | — | 5 | 3% |
| H0251 UnitedHealthcare | UnitedHealth Group, Inc. | 76,188 | 17 | 1 | — | 10 | 3% |
| H3800 Provider Partners Health Plans | Rifkin Managed Care Holding, LLC | 1,079 | 17 | 1 | — | 10 | 3% |
| H4091 Simpra Advantage | Associated Care Ventures, Inc. | 3,553 | 17 | 1 | — | 10 | 3% |
| H3727 Communicare Advantage | SNP Holdings, LLC | 2,314 | 17 | 1 | — | 10 | 3% |
| H2509 UnitedHealthcare | UnitedHealth Group, Inc. | 75,966 | 17 | 1 | — | 10 | 3% |
| H2247 UnitedHealthcare | UnitedHealth Group, Inc. | 39,518 | 17 | 1 | — | 10 | 3% |
| H5628 Molina Healthcare of Utah & Idaho | Molina Healthcare, Inc. | 16,554 | 17 | 1 | — | 10 | 3% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D13 | Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH) | 01/01/2025 – 12/31/2025 | 1 | Prescription Drug Events |